Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ludwig Enterprises Inc (OP: LUDG )

0.1000 UNCHANGED
Streaming Delayed Price Updated: 9:30 AM EDT, May 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.1000
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.1000
Today's Range 0.1000 - 0.1000
52wk Range 0.0180 - 0.4703
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
LUDG Files Genomic Patent AI Uncovers Differentially Expressed Genes
Via ACCESSWIRE
Ludwig Enterprises to Launch New Nutraceutical in Hair Loss Market
Via ACCESSWIRE

Performance

YTD
-63.64%
-63.64%
1 Month
-29.82%
-29.82%
3 Month
-66.56%
-66.56%
6 Month
-60.00%
-60.00%
1 Year
+525.00%
+525.00%

More News

Read More
Ludwig Enterprises Announces Launch of New Nutraceutical and Strategic Marketing Plan
Via ACCESSWIRE
Ludwig Enterprises Launches NuGenea, Groundbreaking Nutraceutical to Fight Inflammation
Via ACCESSWIRE
Decoding mRNA for Early Disease Detection, Treatment & Prevention
Via ACCESSWIRE
Ludwig Enterprises Announces Agreement with Summit Bancorp to Assist with Cross Listing on the Canadian Stock Exchange
Via ACCESSWIRE
Ludwig Enterprises, Inc. (OTC: LUDG) Prepares to Trade on the OTCQB Market
Via ACCESSWIRE
Ludwig Enterprises Receives IRB Approval on Bladder Cancer Study
Via ACCESSWIRE
Ludwig Enterprises Releases Annual 2022 Shareholder Letter
Via ACCESSWIRE
Ludwig Enterprises Announces Intention to List on the Canadian Stock Exchange
Via ACCESSWIRE
Ludwig Enterprises Developing New Partnerships to Fuel Growth
Via ACCESSWIRE
Ludwig Enterprise mRNA Program Generating Broad Clinical Interest
Via ACCESSWIRE
Ludwig Enterprises Announces Brand Name for Groundbreaking Nutraceutical
Via ACCESSWIRE
Ludwig Enterprises Develops Program to Support Ketamine Clinics
Via ACCESSWIRE
Ludwig Enterprises Acquires Cutting-Edge Dietary Supplement Formula
Via ACCESSWIRE
Ludwig Enterprises Announces Progress Towards Planned IPO (S1 Filing)
Via ACCESSWIRE
Precision Genomics (a Ludwig Company) Revealed Major Medical News at a Sequire Spotlight Interview
Via ACCESSWIRE
Precision Genomics Successfully Attends the LD Micro Conference
Via ACCESSWIRE
New Scientific Evidence Suggests How Chronic Illnesses May Be Prevented
Via ACCESSWIRE
Ludwig Enterprises Launches Growth Plan
Via ACCESSWIRE
Precision Genomics’ New mRNA Technology May Be a Solution to Help Diagnose and Establish Treatment for Long Covid
Via ACCESSWIRE
Ludwig’s Genomic-Based mRNA Inflammatory Index - A Ground-Breaking Technology
Via ACCESSWIRE
Ludwig Files a Patent That Could Be a Major Technology Breakthrough in Healthcare
Via ACCESSWIRE
Ludwig Enterprises and Emerson Urology Associates Plan Bladder Cancer BCG Immunotherapy Study
Via ACCESSWIRE
Ludwig Shareholder Letter: Our New Mission and Business Launch
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.